AI100
Automated AI Microscope for Blood & Urine Analysis
Device · HybridCompany source
Company profile
About SigTuple Technologies Pvt.
SigTuple Technologies is a medical technology company that develops AI-powered automated digital microscopy solutions for pathology and laboratory diagnostics. Founded nearly two decades ago after co-founder and CEO Tathagato Rai Dastidar lost his father to misdiagnosis of acute myeloid leukaemia, the company has built a comprehensive platform combining artificial intelligence, robotics, microfluidics, and high-resolution microscopy to automate microscopic analysis of biological samples. With over 10 years of R&D, 27 patents, and 30+ publications, SigTuple has deployed 350+ systems across 7 countries. The company offers three purpose-built platforms: the AS76 (CE-IVDR compliant edge AI digital morphology analyser for peripheral blood smears with true 100X oil immersion), the AI100 (FDA and CE cleared multi-purpose analyser for both peripheral blood smear and urine sediment), and SigVet (point-of-care platform for veterinary clinics). Their technology enables automated cell morphology analysis with pathologist-grade accuracy across 30+ cell types, delivering results in under a minute while maintaining complete data privacy through on-device AI inference. SigTuple serves medium to large laboratories, small to medium laboratories, and veterinary clinics, with particular impact in rural and underserved healthcare settings across India and globally. The company has partnered with major healthcare organizations including Krsnaa Diagnostics, HCG hospitals, and HORIBA, and has been recognized as one of the top 100 health tech companies in South Asia.
Company description SigTuple Technologies Pvt. official website
Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at SigTuple Technologies Pvt.?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- All types of anaemias
- All types of blood cancers
- Dengue
- Leukaemia
- Malaria
- Parasitic infections
- Viral infections
Who it serves
- Diagnostic chains
- Medium and large laboratories
- Rural hospitals
- Small and medium laboratories
- Tribal hospitals
- Veterinary clinics
Deployment & integration
Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: Bidirectional LIS Integration.
Geographic context
Markets7 countries globally · India · Rural Maharashtra · Tamil Nadu · United States (FDA cleared)
Company sourceOfficial website
Company milestones
Platform expansion
U.S. FDA approval for AI100 blood smear application with Shonit, HORIBA partnership adding AI100 to their portfolio, HCG hospitals adoption of AI100, 350+ deployments across 7 countries, recognized as top 100 health tech company in South Asia
Partnerships
Recorded partners
- HCG hospitals (HealthCare Global Enterprises Ltd)
- HORIBA
- Indian Institute of Science
- Krsnaa Diagnostics
- Silicon Valley Bank (SVB)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AS76
Edge AI Digital Morphology Analyser for Peripheral Blood Smear
Device · On PremiseCompany source
SigVet
Multi-test AI-powered point-of-care platform for veterinary clinics
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
AI Driven Lab-on-Chip Cartridge for Automated Urinalysis.SLAS technology · Jun 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
AI100 with ShonitK221309 · 510k · Sep 19, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Results in under a minute
Automated microscopic analysis
200-cell leukocyte differential
AS76 peripheral blood smear analysis
2,000+ RBCs analysed
AS76 morphology assessment with ICSH-based grading
30+ cell types at pathologist-grade accuracy
Automated digital microscopy
Near-instant results
Edge AI processing with no cloud round-trip
HealthCare Global Enterprises Ltd (HCG)
Automate manual microscopy screening process
Adopted AI100 to automate manual microscopy screening across hospital network
Krsnaa Diagnostics
Scale quality care to rural India by replacing inconsistent manual review with automated, reproducible analysis
Expanded access to reliable, standardised diagnostics across rural India at scale
Rural Hospital in Maharashtra
Early leukaemia detection in rural Maharashtra where specialist pathologists are scarce
Enabled early detection and timely treatment initiation for leukaemia in region with delayed critical diagnoses
Tribal Hospital in Gudalur, Tamil Nadu
AI-driven lab diagnostics in remote tribal hospital to deliver microscopic testing to patients with no prior access
Transformed village health centre into capable diagnostic unit overnight
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Tathagato Rai Dastidar
Co-Founder & CEO
06 · Company updates
Updates from SigTuple Technologies Pvt.
Recent articles published on SigTuple Technologies Pvt.'s official website.
Joe Bidenâs cancer has spread further: Son Hunter
Read on SigTuple Technologies Pvt.Audi makes its biggest India bet yet amid luxury chill
Read on SigTuple Technologies Pvt.Top IT stocks stare at great valuation reset
Read on SigTuple Technologies Pvt.Trump's Marine One in safety lapse, US orders probe
Read on SigTuple Technologies Pvt.Oil prices jump after US' fresh strikes against Iran
Read on SigTuple Technologies Pvt.07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pathology & Laboratory Diagnostics
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.